Medicine and Dentistry
Rheumatoid Arthritis
100%
Alpha Adrenergic Receptor Blocking
100%
Standing
100%
Tumor Necrosis Factor
100%
Endothelial Dysfunction
100%
Inpatient
100%
Infliximab
66%
Patient
66%
Combination Therapy
50%
Infusion
50%
Endothelial Function
33%
Monoclonals
33%
Methotrexate
16%
Rheumatic Disease
16%
Cardiovascular Disease
16%
Biological Marker
16%
Echography
16%
Cell Adhesion Molecule
16%
Vasculotropin
16%
C Reactive Protein
16%
Endothelial Leukocyte Adhesion Molecule 1
16%
Brachial Artery
16%
Vasodilatation
16%
Tumor Necrosis Factor Antibody
16%
Symptom
16%
Cell Adhesion Molecule 1
16%
Vascular Cell Adhesion Molecule 1
16%
Therapeutic Procedure
16%
Aptitude
16%
Plasma
16%
Atherosclerosis
16%
Immunology and Microbiology
Inflammatory Arthritis
100%
Tumor Necrosis Factor Alpha
100%
Alpha Adrenergic Receptor Blocking
100%
Standing
100%
Infliximab
66%
Flow
50%
Methotrexate
16%
Rheumatic Disease
16%
Blood Level
16%
Vasculotropin
16%
C-Reactive Protein
16%
Adhesion Molecule
16%
Atherosclerosis
16%
Tumor Necrosis Factor Antibody
16%
Cell Adhesion Molecule 1
16%
VCAM-1
16%
Vasodilatation
16%
Brachial Artery
16%
E-Selectin
16%
Artery Diameter
16%
Time
16%
Aptitude
16%